Cite Filings / UTHR / 0000093751-25-000066
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SCHEDULE 13G

Statement of Beneficial Ownership

UNITED THERAPEUTICS Corp · Filed 2025-02-05 · Acc 0000093751-25-000066

Documents 1

  • SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

  • 2026-02-10 SCHEDULE 13G Statement of Beneficial Ownership
  • 2025-02-11 4 PRESIDENT AND COO sold 10,000 shares at an average $348.06 ($3,480,642)
  • 2025-02-10 144 Sale of Securities
  • 2025-02-10 4 EVP & GENERAL COUNSEL returned 7,700 shares (to the company)
  • 2025-02-10 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2025-02-05 SCHEDULE 13G Statement of Beneficial Ownership
  • 2025-02-04 4 PRESIDENT AND COO sold 10,000 shares at an average $353.64 ($3,536,398)

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…